Lantern Pharma (LTRN) - P/B ratio
P/B ratio as of January 2025 : 1.52
According to Lantern Pharma's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
P/B ratio by year
Year |
P/B ratio |
Change |
2024-12-31 | 1.39 | 23.59% |
2023-12-31 | 1.12 | -4.12% |
2022-12-31 | 1.17 | -6.19% |
2021-12-31 | 1.25 | -79.47% |
2020-12-31 | 6.08 | |
2019-12-31 | N/A | |
P/B ratio for similar companies or competitors
Company | P/B ratio | P/B ratio differencediff. | Country |
| 2.09 | 36.92% | ๐บ๐ธ USA |